Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 3 1Phase 1/2 1Phase 1 1

Status

Recruiting 9Unknown 4Not yet recruiting 2Withdrawn 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 219Neoplasms 177Lung Neoplasms 92Prostatic Neoplasms 89Colorectal Neoplasms 88Carcinoma, Non-Small-Cell Lung 48Stomach Neoplasms 45Motor Activity 45Carcinoma, Hepatocellular 45Pancreatic Neoplasms 40Uterine Cervical Neoplasms 39Anxiety Disorders 39Rectal Neoplasms 34Head and Neck Neoplasms 31Colonic Neoplasms 30Pain 26Depression 26Brain Neoplasms 25Polycystic Ovary Syndrome 24Esophageal Neoplasms 24Disease 23Multiple Myeloma 22Hematologic Neoplasms 22Endometrial Neoplasms 22Ovarian Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Urinary Bladder Neoplasms 18Pain, Postoperative 18Glioblastoma 18Liver Neoplasms 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × Pathologic Complete Response × Clear all
NCT07164872 2025-09-10

Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Not yet recruiting
50 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

NCT04225858 2020-01-13

ASICS

The Netherlands Cancer Institute

Phase NA Not yet recruiting
340 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡